104 related articles for article (PubMed ID: 7981362)
41. Early onset of evans syndrome following autologous peripheral blood progenitor cell transplantation in a child.
Gonzalez-Vicent M; Diaz MA; Garcia-Sanchez F; Molina J; Madero L
Haematologica; 2002 May; 87(5):ECR17. PubMed ID: 12010680
[No Abstract] [Full Text] [Related]
42. [A case of Evans's syndrome in which thrombocytopenia and hemolysis was improved by Sairei-to].
Horikoshi A; Shida M; Abe M; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 1995 Oct; 36(10):1237-9. PubMed ID: 8531338
[TBL] [Abstract][Full Text] [Related]
43. Evans syndrome: successful management with multi-agent treatment including intermediate-dose intravenous cyclophosphamide.
Gombakis N; Trahana M; Athanassiou M; Kanakoudi-Tsakalidou F
J Pediatr Hematol Oncol; 1999; 21(3):248-9. PubMed ID: 10363861
[No Abstract] [Full Text] [Related]
44. [Basedow disease associated with Evans syndrome].
Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Matsumoto M
Rinsho Ketsueki; 2005 Oct; 46(10):1118-22. PubMed ID: 16440774
[TBL] [Abstract][Full Text] [Related]
45. [Anemia and hemorrhagic diathesis in autoimmune hemolysis and immune thrombocytopenia].
Stemmler HJ; Ochmann O; Pihusch R; Hiller E
Internist (Berl); 1996 Jan; 37(1):78-81. PubMed ID: 8837831
[No Abstract] [Full Text] [Related]
46. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
47. [The combination therapy with vinca-alkaloid slow infusion and cholchicine was effective to refractory idiopathic thrombocytopenic purpura. The patient could receive femoral head replacement in safety].
Nezu M; Oh H; Cho R; Sato H; Ikegami T; Yokota A; Nakaseko C; Nishimura M; Matsuura Y; Morio S; Hiruma K; Nakamura H; Asai T
Rinsho Ketsueki; 1996 Feb; 37(2):158-60. PubMed ID: 8852035
[TBL] [Abstract][Full Text] [Related]
48. Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. A case report.
Gross Z; Rodriguez JJ; Stalnaker BL
J Reprod Med; 1995 Oct; 40(10):739-42. PubMed ID: 8551481
[TBL] [Abstract][Full Text] [Related]
49. Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report.
Martino R; Sureda A; Brunet S
Bone Marrow Transplant; 1997 Sep; 20(6):521. PubMed ID: 9313889
[No Abstract] [Full Text] [Related]
50. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
[TBL] [Abstract][Full Text] [Related]
51. Vinblastine and danazol therapy in steroid resistant childhood chronic idiopathic thrombocytopenic purpura.
Choudhry VP; Kashyap R; Ahlawat S; Pati HP
Int J Hematol; 1995 Apr; 61(3):157-62. PubMed ID: 7599327
[TBL] [Abstract][Full Text] [Related]
52. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
53. [Treatment and results of therapy in autoimmune hemolytic anemia].
Tasić J; Macukanović L; Pavlović M; Koraćević S; Govedarević N; Kitić Lj; Tijanić I; Bakić M
Srp Arh Celok Lek; 1994; 122 Suppl 1():101-2. PubMed ID: 18173205
[TBL] [Abstract][Full Text] [Related]
54. Management of a young patient with combined autoimmunity: Evans syndrome: a case report.
Pinto A; Lindemeyer RG; Alawi F
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Apr; 103(4):505-11. PubMed ID: 17095266
[TBL] [Abstract][Full Text] [Related]
55. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
[TBL] [Abstract][Full Text] [Related]
56. Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab).
Narang M; Penner JA; Williams D
Am J Hematol; 2003 Dec; 74(4):263-7. PubMed ID: 14635207
[TBL] [Abstract][Full Text] [Related]
57. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
[TBL] [Abstract][Full Text] [Related]
58. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
59. Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone.
Rackoff WR; Manno CS
Am J Pediatr Hematol Oncol; 1994 May; 16(2):156-9. PubMed ID: 8166369
[TBL] [Abstract][Full Text] [Related]
60. Salvage therapy and long-term remission with danazol and cyclosporine in refractory Evan's syndrome.
Chemlal K; Wyplosz B; Grange MJ; Lassoued K; Clauvel JP
Am J Hematol; 1999 Nov; 62(3):200. PubMed ID: 10539891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
